Cureline, Inc.is a global biosample management company providing effective solutions for scientifically challenging projects. The company was founded by a group of scientists and business development professionals who established the biorepository for SUGEN, Inc. and participated in the development ofSutent® (Pfizer Inc).


Cureline Clinical Consulting Partners

CCCP is a regional clinical research organization (CRO) providing clinical developmental services throughout Russia and the former Soviet republics.

•  Clinical Trial Management
•  Regulatory Affairs
•  Clinical Contract Staffing

Cureline BioPathology Laboratory

Comprehensive histology analysis on human and animal tissues including clinical laboratory services for the San Francisco Bay area clients.

For detailed information about available services and prices, visit  www.CurelineBiopathology.com













Since 2003, Cureline, Inc. has been dedicated to innovation inhuman tissue research. Using our team's scientific and clinical expertise, we have developed multi-site international collaborations and have implemented protocols for obtaining, handling and processing of human specimens worldwide.  Since its inception, the primary focus of our company has been oncology, including solid tumors and hematologic malignancies.  Every year our procurement network expands to new therapeutic areas and new countries and now we conduct projects in neurology, inflammation and metabolic and cardiovascular diseases.

Cureline, Inc. is a preferred provider for biospecimens and custom tissue procurement services forVWR International LLC, a company dedicated to drug discovery and development services.

To address the growing need for high-quality human tissue processing and analysis, Cureline founded in 2007Cureline BioPathology, a research histology laboratory providing services in quality tissue processing and preparation, target profiling, antibody cross-reactivity studies and toxicology. Both companies recently relocated to a newly renovated building in Burlingame, CA that contains over 3,000 square feet of administrative space and a state-of the art laboratory facility.


Recently developed tissue acquisition and research protocols

     Primary cell lines from solid tumors, hematological cancers and normal tissues

     Viable epitope- specific cell fractions from blood and bone marrow 

     Procurement of biospecimen sets (tissue biopsy, synovial fluid, PBMCs, serum, etc.) from patients with inflammatory diseases (rheumatoid arthritis, lupus, etc.)


Download our brochure